MMCAP International’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

MMCAP International’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73,525	Closed	-$21.9K	–	359
2022 Q4	$21.9K	Hold	73,525	–	–	﹤0.01%	269
2022 Q3	$7K	Hold	73,525	–	–	﹤0.01%	436
2022 Q2	$11K	Hold	73,525	–	–	﹤0.01%	441
2022 Q1	$15K	Sell	73,525 -3,900	-5%	-$1.82K	﹤0.01%	492
2021 Q4	$46K	Hold	77,425	–	–	﹤0.01%	413
2021 Q3	$48K	Sell	77,425 -5,908	-7%	-$4.6K	﹤0.01%	391
2021 Q2	$79K	Buy	+83,333	New	+$77.5K	﹤0.01%	359

MMCAP International's EBACW Position: Q1 2023 in Review

MMCAP International sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 73,525 shares — an estimated $21.9K sold.

MMCAP International first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $79K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

MMCAP International reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
MMCAP International sold 73,525 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $21.9K.
MMCAP International first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
MMCAP International's European Biotech Acquisition Corp. Warrant position peaked at $79K in Q2 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.